var data={"title":"Glucocorticoid effects on the nervous system and behavior","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Glucocorticoid effects on the nervous system and behavior</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/contributors\" class=\"contributor contributor_credentials\">Andr&eacute; Lacroix, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/contributors\" class=\"contributor contributor_credentials\">Lynnette K Nieman, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/contributors\" class=\"contributor contributor_credentials\">Kathryn A Martin, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Mar 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Aug 21, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Glucocorticoids play an important role in the function and homeostasis of the central nervous system. Chronic exposure to supraphysiological levels of glucocorticoids in Cushing's syndrome is associated with anatomical brain changes and an increased prevalence of psychiatric diseases, cognitive impairment, mood alterations, and sleep disturbances [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/1-5\" class=\"abstract_t\">1-5</a>]. The effects of glucocorticoids on the nervous system and behavior will be discussed here; effects on other systems are reviewed separately. (See <a href=\"topic.htm?path=clinical-features-and-evaluation-of-glucocorticoid-induced-osteoporosis\" class=\"medical medical_review\">&quot;Clinical features and evaluation of glucocorticoid-induced osteoporosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">EFFECTS ON CENTRAL NERVOUS SYSTEM</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>At the cellular level, glucocorticoids exert several actions on the central nervous system.</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h2\">Intracellular receptors</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Glucocorticoids penetrate the brain and bind to two types of intracellular receptors: glucocorticoid receptors, which are expressed in cerebral neurons and glial cells, and mineralocorticoid receptors, which are mainly expressed in limbic brain areas such as the hippocampus. Mineralocorticoid receptors bind cortisol with an affinity 10-fold higher than glucocorticoid receptors [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/4\" class=\"abstract_t\">4</a>].</p><p>Low basal cortisol levels predominantly occupy high-affinity mineralocorticoid receptors, whereas glucocorticoid receptors can also be activated when glucocorticoid concentrations are elevated, such as during the active period of the circadian cycle or stress, and in Cushing's syndrome [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/4,6-8\" class=\"abstract_t\">4,6-8</a>].</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Metabolism of glucocorticoids</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Metabolism of glucocorticoids occurs intracellularly and is mediated by 11-beta-hydroxysteroid dehydrogenases (11b-HSDs) [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/8,9\" class=\"abstract_t\">8,9</a>]. There are two isoforms of 11b-HSDs: type 1, which elevates intracellular cortisol levels, and type 2, which inactivates glucocorticoids by converting cortisol into the inactive cortisone molecule.</p><p>In hippocampal cells, only 11b-HSD type 1 is expressed, leading to conversion to cortisol. Because 11b-HSD type 2 is not expressed in the hippocampus or other limbic structures, mineralocorticoid receptor activation by glucocorticoids occurs in these brain areas [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/10\" class=\"abstract_t\">10</a>].</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Acute versus chronic effects</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Certain effects of glucocorticoids occur so rapidly (ie, within two minutes after exposure to the hormone) that a direct membrane effect is likely [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/11\" class=\"abstract_t\">11</a>]. These responses include changes in the electrical activity of neurons, such as hyperpolarization of cell membranes [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/12\" class=\"abstract_t\">12</a>] or suppression of spontaneous electrical activity [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/13,14\" class=\"abstract_t\">13,14</a>]. Hyperpolarization is blocked by antiglucocorticoids, suggesting involvement of a receptor-like molecule [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/13\" class=\"abstract_t\">13</a>].</p><p>The effects of more chronic exposure to glucocorticoids include inhibition of the regenerative sprouting of axons that follows differentiation of hippocampal neurons [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/15,16\" class=\"abstract_t\">15,16</a>] and reduction in the number of these neurons [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/17\" class=\"abstract_t\">17</a>]. High levels of glucocorticoids induce increases in oxidative stress damage in mitochondria and decrease transport of mitochondria to synaptic regions where neurotransmitter release occurs. In brain cells, the glucocorticoid receptor is translocated from the cytosol to the mitochondria; stress and corticosteroids have a direct influence on mitochondrial DNA transcription and mitochondrial physiology [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/18\" class=\"abstract_t\">18</a>]. </p><p>Brain-derived neurotrophic factor (BDNF) is involved in many functions, such as neuronal growth, survival, synaptic plasticity, and memorization; glucocorticoid receptors downregulate BDNF expression [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/19\" class=\"abstract_t\">19</a>].</p><p>Glial cells also appear to be targets for glucocorticoids. As an example, glucocorticoids induce glutamine synthetase activity in cultured astrocytes [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/20-22\" class=\"abstract_t\">20-22</a>] and glycerol-3-phosphate dehydrogenase activity in cultured oligodendrocytes [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/23,24\" class=\"abstract_t\">23,24</a>]. These effects appear to be exerted at the transcriptional level [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/25\" class=\"abstract_t\">25</a>].</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">Apoptosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Glucocorticoids stimulate apoptosis of cells in several tissues:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>T-lymphocytes of the immune system</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In hippocampal neurons, chronic hypercortisolemia leads to atrophy and cell death [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/26\" class=\"abstract_t\">26</a>]</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In rats, increased corticosterone levels induced by sleep deprivation results in decreased neurogenesis in the hippocampus [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/27\" class=\"abstract_t\">27</a>]</p><p/><p>In contrast, in glial cells, glucocorticoids stimulate expression of the cellular inhibitor of apoptosis-2, protecting them from cell death [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/28\" class=\"abstract_t\">28</a>].</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h1\">AUTONOMIC NERVOUS SYSTEM AND ADRENAL MEDULLA</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>It is not known if there are major clinical effects of hypercortisolism on the autonomic nervous system. Glucocorticoids are important for the normal development and function of the adrenal medulla, and their deficiency leads to abnormal medullary structure and decreased epinephrine secretion [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/29,30\" class=\"abstract_t\">29,30</a>]. However, the hypertension in patients with Cushing's syndrome is not caused by excess catecholamine secretion. (See <a href=\"topic.htm?path=epidemiology-and-clinical-manifestations-of-cushings-syndrome#H2070761869\" class=\"medical medical_review\">&quot;Epidemiology and clinical manifestations of Cushing's syndrome&quot;, section on 'Cardiovascular'</a>.)</p><p>Glucocorticoids stimulate the differentiation of neural crest epithelial cells into chromaffin cells. Neural crest cells are precursors for a variety of more differentiated cell types, including autonomic ganglion cells and adrenal medullary cells [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/31\" class=\"abstract_t\">31</a>].</p><p>Under the influence of nerve growth factor (NGF), for example, sympathetic ganglion cells enlarge, develop neuronal processes and synaptic vesicles, and produce a variety of neuron-specific proteins, such as SCG-10, GAP-43 (believed to be involved in neuronal growth and plasticity), and NF-68 (a neurofilament component) [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/32-35\" class=\"abstract_t\">32-35</a>].</p><p>Under the influence of glucocorticoids, neural crest precursor cells that invade the embryonic adrenal gland cease to express &quot;neuron-specific&quot; gene products, such as neurofilaments, and acquire the characteristic morphology of adrenomedullary chromaffin cells [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/34\" class=\"abstract_t\">34</a>]. They also lose their neural processes and begin to produce catecholamine-synthesizing enzymes, such as phenylethanolamine-N-methyltransferase, which converts norepinephrine to epinephrine. The exact mechanism by which glucocorticoids induce this differentiation is not known.</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h1\">EFFECTS OF GLUCOCORTICOID EXCESS</span></p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h2\">Behavior</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Glucocorticoids have effects on behavior in humans, including cognition, mood, and modulation of sleep patterns [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/3,36,37\" class=\"abstract_t\">3,36,37</a>].</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h3\">Cognition and memory</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Glucocorticoids affect cognitive function through their effects on the hippocampus, an area that is critical to the processing and storage of memory. Normal to moderately elevated levels of glucocorticoids facilitate learning and memory processes, but chronic exposure to high cortisol concentrations may cause long-lasting deficits in attention, visuospatial processing, memory, conditional response, reasoning, and verbal fluency [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/5,38-40\" class=\"abstract_t\">5,38-40</a>]. The deficit appears to be mainly in information recall, rather than in its acquisition [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/41\" class=\"abstract_t\">41</a>]. Acute administration of 0.4 mg of the mineralocorticoid receptor agonist <a href=\"topic.htm?path=fludrocortisone-drug-information\" class=\"drug drug_general\">fludrocortisone</a> improved visuospatial, short-term, and working memory in young and older individuals [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/42\" class=\"abstract_t\">42</a>].</p><p>In addition to confirming verbal learning and delayed recall impairments, a study of 15 female patients with endogenous Cushing's syndrome found additional deficits in slow learning rate, short-term memory volume, memory contamination, and false appraisal of task performance, which suggest extrahippocampal effects of glucocorticoids on memory impairment [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/37\" class=\"abstract_t\">37</a>]. Subtle cognitive and memory defects may persist after treatment and resolution of hypercortisolism. (See <a href=\"topic.htm?path=epidemiology-and-clinical-manifestations-of-cushings-syndrome#H563140511\" class=\"medical medical_review\">&quot;Epidemiology and clinical manifestations of Cushing's syndrome&quot;, section on 'Neuropsychologic changes and cognition'</a>.)</p><p>Acute exposure to intravenous <a href=\"topic.htm?path=methylprednisolone-drug-information\" class=\"drug drug_general\">methylprednisolone</a> (500 mg daily during five days) in 30 patients with optic neuritis or multiple sclerosis also produced a rapidly reversible effect on long-term memory, but not on short-term memory, or attentional or alertness tasks [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/43\" class=\"abstract_t\">43</a>].</p><p>Brain-derived neurotrophic factor (BDNF) is necessary for memory formation and protects against stress-dependent impairment of spatial memory [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/44\" class=\"abstract_t\">44</a>]. Its expression is decreased by excess glucocorticoids [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/19\" class=\"abstract_t\">19</a>]. </p><p>Glucocorticoids may also affect cognitive function through effects on the frontal lobes and amygdala [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/45\" class=\"abstract_t\">45</a>].</p><p>The hippocampus also projects axons to the paraventricular nucleus. Activation of these neurons inhibits the secretion of corticotropin-releasing hormone (CRH) and arginine vasopressin into the hypophysial portal blood and, thus, corticotropin (ACTH) secretion by the anterior pituitary. This action is mediated both by glucocorticoids and by gamma-amino butyric acid, for which there are receptors in both the hippocampus and paraventricular nucleus [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/46\" class=\"abstract_t\">46</a>].</p><p>Stimulation of the mineralocorticoid receptor improves memory in young and older healthy individuals; occupancy of mineralocorticoid receptor with low doses of <a href=\"topic.htm?path=hydrocortisone-drug-information\" class=\"drug drug_general\">hydrocortisone</a> improves memory deficit produced by chronic administration of <a href=\"topic.htm?path=dexamethasone-drug-information\" class=\"drug drug_general\">dexamethasone</a> for various medical conditions [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/42,47\" class=\"abstract_t\">42,47</a>].</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h3\">Mood</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The evidence for glucocorticoid-induced alterations in mood and cognitive function comes largely from clinical observations. When evaluated by formal psychiatric interview, approximately one-half of patients with either spontaneous or iatrogenic Cushing's syndrome have a psychiatric diagnosis based upon Diagnostic and Statistical Manual of Mental Disorders (DSM) criteria, depression being the most common [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/3,21\" class=\"abstract_t\">3,21</a>]. (See <a href=\"topic.htm?path=epidemiology-and-clinical-manifestations-of-cushings-syndrome#H563140511\" class=\"medical medical_review\">&quot;Epidemiology and clinical manifestations of Cushing's syndrome&quot;, section on 'Neuropsychologic changes and cognition'</a>.)</p><p>Patients with exogenous Cushing's syndrome have been thought to have euphoria more often than those with endogenous Cushing's, but if so, it is probably because of relief of symptoms of the disorder for which glucocorticoid therapy was given.</p><p>Varying degrees of manic behavior and even overt psychosis can occur. Many patients have a more subtle disturbance in mood, especially lability and irritability [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/48\" class=\"abstract_t\">48</a>]. Mood symptoms may persist in spite of treatment and resolution of hypercortisolism [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/3\" class=\"abstract_t\">3</a>]. (See <a href=\"topic.htm?path=epidemiology-and-clinical-manifestations-of-cushings-syndrome#H563140511\" class=\"medical medical_review\">&quot;Epidemiology and clinical manifestations of Cushing's syndrome&quot;, section on 'Neuropsychologic changes and cognition'</a>.) </p><p>Patients with adrenal insufficiency also may have psychiatric disturbances, mainly depression, apathy, and lethargy. The mechanisms that mediate these behavioral effects of glucocorticoids are unknown.</p><p>There is evidence of hypothalamic-pituitary-adrenal hyperactivity (pseudo-Cushing's syndrome) in patients with mood disorders, particularly in patients with acute major depressive disorder [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/49\" class=\"abstract_t\">49</a>]. Some investigators have reported success in treating depression with adrenal steroidogenic enzyme inhibitors or glucocorticoid antagonists [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/50\" class=\"abstract_t\">50</a>]. Major depressive disorder may be considered, at least in part, as a dysregulation of the response to stress [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/51\" class=\"abstract_t\">51</a>]. (See <a href=\"topic.htm?path=epidemiology-and-clinical-manifestations-of-cushings-syndrome#H563140511\" class=\"medical medical_review\">&quot;Epidemiology and clinical manifestations of Cushing's syndrome&quot;, section on 'Neuropsychologic changes and cognition'</a>.)</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h3\">Sleep</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The duration of rapid eye movement (REM) sleep is decreased in patients with Cushing's syndrome and in normal subjects given high doses of glucocorticoids or in whom endogenous cortisol secretion is stimulated by corticotropin. (See <a href=\"topic.htm?path=epidemiology-and-clinical-manifestations-of-cushings-syndrome#H563140511\" class=\"medical medical_review\">&quot;Epidemiology and clinical manifestations of Cushing's syndrome&quot;, section on 'Neuropsychologic changes and cognition'</a>.)</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h2\">Loss of brain volume</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Several studies have examined the effects of glucocorticoid excess on brain structures in humans [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/2\" class=\"abstract_t\">2</a>]. In patients with Cushing's syndrome, autopsy studies demonstrate lower brain weight, loss of brain volume, and ventricular enlargement [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/52-56\" class=\"abstract_t\">52-56</a>]. As an example, in a pneumoencephalographic study of 31 patients with Cushing's disease, cortical atrophy was present in the cerebral or cerebellar hemispheres in 90 and 74 percent of patients, respectively [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/53\" class=\"abstract_t\">53</a>]. In addition, hippocampal volume was reduced in 27 percent of the patients in this study. In another study, an association was found between elevated cortisol levels, reduced hippocampal formation, and memory dysfunction, suggesting a possible link between anatomic structure and neuropsychological function [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/57\" class=\"abstract_t\">57</a>].</p><p>More diffuse loss of brain volume was found in 63 patients with Cushing's disease, compared with an age- and sex-matched control group studied using computed tomography (CT) and magnetic resonance imaging (MRI) scans [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/58\" class=\"abstract_t\">58</a>]. The cerebellar cortex volume was also smaller in patients with active Cushing's syndrome than in controls, and this was associated with poor visual memory and quality of life and was more pronounced in patients with older age at diagnosis [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/59\" class=\"abstract_t\">59</a>].</p><p>Exogenous glucocorticoids have similar effects to those of endogenous glucocorticoids on brain volume. In a study of patients under age 40 years with a diagnosis of cerebral atrophy, approximately 10 percent were on chronic glucocorticoid therapy [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/60\" class=\"abstract_t\">60</a>]. In a second study, pharmacologic doses of glucocorticoids were associated with cerebral atrophy in two groups of either systemic lupus erythematosus or non-lupus patients compared with age- and gender-matched normal subjects [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/61\" class=\"abstract_t\">61</a>].</p><p>Other studies also report a possible link between cerebral atrophy and conditions associated with the increased endogenous secretion of cortisol including alcoholism [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/62\" class=\"abstract_t\">62</a>], endogenous depression [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/63-65\" class=\"abstract_t\">63-65</a>], and posttraumatic stress syndrome [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/66\" class=\"abstract_t\">66</a>].</p><p>The hippocampi of 10 neonates who had been treated with antenatal glucocorticoids (typically mothers received two intramuscular doses of 12 mg <a href=\"topic.htm?path=betamethasone-drug-information\" class=\"drug drug_general\">betamethasone</a> with a 24-hour interval) showed a lower density of neurons and particularly large neurons as compared with those of 11 neonates who were not exposed to antenatal glucocorticoids [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/67\" class=\"abstract_t\">67</a>].</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h2\">Brain metabolic and functional changes</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A significant decrease in the choline-to-creatine ratio <span class=\"nowrap\">(Cho/Cr),</span> a membrane marker of phosphatidylcholine metabolism, was measured by proton magnetic resonance spectroscopy (MRS) in the frontal (-24 percent) and thalamic (-17 percent) areas, but not in temporal areas, of 13 patients with Cushing's syndrome (7 pituitary, 6 adrenal) as compared with 40 normal control subjects [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/68\" class=\"abstract_t\">68</a>]. The other metabolite ratios, ie, N-acetylaspartate <span class=\"nowrap\">(NAA/Cr),</span> a neuron marker, and myo-inositol <span class=\"nowrap\">(mI/Cr),</span> a glial marker, were unaffected by Cushing's syndrome [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/68\" class=\"abstract_t\">68</a>]. In Cushing's disease patients, glucose uptake was decreased in several brain regions, mainly hippocampus, amygdala, and cerebellum but also in the frontal and occipital cortex, as assessed by 18F-fluorodeoxyglucose positron emission tomography [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/69\" class=\"abstract_t\">69</a>].</p><p>The effects of exogenous glucocorticoids on brain proton MRS were also investigated in 13 patients treated with 5 to 50 mg of <a href=\"topic.htm?path=prednisone-drug-information\" class=\"drug drug_general\">prednisone</a> per day for periods varying between 2 to 22 years for various pathological conditions; compared with normal subjects, none of the MRS metabolites reached a significant change, but a decrease of 1.3 percent per year of the <span class=\"nowrap\">Cho/H<sub>2</sub>O</span> ratio was found as a function of the treatment period [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/70\" class=\"abstract_t\">70</a>].</p><p>In a group of 12 adolescents with endogenous Cushing's syndrome, functional MRI during an emotional faces encoding task showed greater left amygdala and right anterior hippocampus activation in patients compared with 22 healthy, adolescent controls [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/71\" class=\"abstract_t\">71</a>]. As adolescents with Cushing's syndrome appear to be less likely to develop mood disorders than their adult counterparts, this functional activation may represent protective neutral mechanisms at that stage of cerebral development.</p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h1\">CORRECTION OF HYPERCORTISOLISM</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Correction of hypercortisolism results in improvement, but not normalization, of brain volume or cognitive function [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/2\" class=\"abstract_t\">2</a>], as illustrated by the following findings (see <a href=\"topic.htm?path=epidemiology-and-clinical-manifestations-of-cushings-syndrome#H563140511\" class=\"medical medical_review\">&quot;Epidemiology and clinical manifestations of Cushing's syndrome&quot;, section on 'Neuropsychologic changes and cognition'</a>):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In 22 adult patients with endogenous Cushing's syndrome studied 39.7&plusmn;34.1 months after achieving eucortisolism, the measures of apparent brain volume loss improved significantly but did not reach the normal control group values [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/56\" class=\"abstract_t\">56</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The volume of hippocampal formation increased significantly by 3 percent following treatment in 22 patients with Cushing's syndrome with a mean follow-up of 16&plusmn;9.3 months, and this increase was found to correlate significantly with the reduction in urinary free cortisol levels [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/72\" class=\"abstract_t\">72</a>]. In 10 patients studied 12 months after pituitary surgery for Cushing's disease, a significant increase in volume was noted in the hippocampal head region [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/73\" class=\"abstract_t\">73</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In 12 children with Cushing's syndrome, correction of hypercortisolism completely reversed the apparent cerebral atrophy within one year, but cognitive decline was not corrected simultaneously [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/52\" class=\"abstract_t\">52</a>]. In a group of children with corticotropin (ACTH)-dependent Cushing's syndrome, psychiatric morbidities deteriorated despite remission of hypercortisolism [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/74\" class=\"abstract_t\">74</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Alterations in decision making were related to persistent reduction in cortical thickness in frontal areas in 35 patients with endocrine remission of their Cushing's syndrome [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/75\" class=\"abstract_t\">75</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Limited improvement in cognitive performance occurred even after 36 months of achieving eucortisolism in 18 patients with endogenous Cushing's syndrome [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/76\" class=\"abstract_t\">76</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Twenty-two patients in remission of Cushing's disease showed widespread changes of white matter integrity in the brain, which was related to the severity of depressive symptoms, suggesting persistent structural effects of hypercortisolism [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/77\" class=\"abstract_t\">77</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The brain metabolic changes described above also appear to improve with correction of hypercortisolism [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/78\" class=\"abstract_t\">78</a>]. However, abnormal metabolites persisted in the hippocampi of Cushing's syndrome patients, despite correction of their hypercortisolism (15 pituitary, three adrenal) [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/79\" class=\"abstract_t\">79</a>]. The alterations in metabolites correlated with measures of anxiety [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/80\" class=\"abstract_t\">80</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Decreased functional coupling was identified between the ventromedial prefrontal cortex and posterior cingulate cortex in Cushing's disease patients in remission during functional magnetic resonance imaging (MRI) studies, confirming a link between structural and neuropsychopathology functions [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/81,82\" class=\"abstract_t\">81,82</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>White matter alterations assessed by diffusion tensor MRI in patients with Cushing's syndrome suggest diffuse loss of white matter integrity and demyelination, which persists after remission or cure [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/83\" class=\"abstract_t\">83</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Low blood brain-derived neurotrophic factor (BDNF) levels are associated with affective alterations in Cushing's syndrome patients in remission, including depression, anxiety, and impaired stress perception [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/84\" class=\"abstract_t\">84</a>].</p><p/><p>The loss of brain volume observed in patients with Cushing's syndrome is likely multifactorial and includes loss in water content in the brain, catabolic effects on proteins, neuronal and dendritic atrophy, and possibly neuronal <span class=\"nowrap\">and/or</span> glial cell death. The rapid reversibility observed may reflect the reversibility of brain water content redistribution and of neuronal cell volume. The incompleteness of the reversibility suggests a permanent neuronal loss, possibly as a later stage of chronic exposure to elevated glucocorticoid levels [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/3\" class=\"abstract_t\">3</a>].</p><p>In a group of 51 patients with long-term cured Cushing's disease, an increased prevalence of psychopathology and maladaptive personality traits remained despite mean duration of remission of 11 years. Compared with nonfunctioning pituitary macroadenoma patients, patients treated for Cushing's disease scored worse on apathy, irritability, anxiety, negative affect, and lack of positive affect and somatic arousal. These observations indicate that some effects of previous glucocorticoid excess on the central nervous system are not completely reversible [<a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/85\" class=\"abstract_t\">85</a>].</p><p class=\"headingAnchor\" id=\"H16\"><span class=\"h1\">SUMMARY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Glucocorticoids play an important role in the function and homeostasis of the central nervous system. Chronic exposure to supraphysiological levels of glucocorticoids in Cushing's syndrome is associated with anatomical brain changes and an increased prevalence of psychiatric diseases, cognitive impairment, mood alterations, and sleep disturbances. (See <a href=\"topic.htm?path=epidemiology-and-clinical-manifestations-of-cushings-syndrome#H563140511\" class=\"medical medical_review\">&quot;Epidemiology and clinical manifestations of Cushing's syndrome&quot;, section on 'Neuropsychologic changes and cognition'</a>.)</p><p>Correction of hypercortisolism results in improvement, but not normalization, of brain volume, cognitive function, and mood disorders. (See <a href=\"#H15\" class=\"local\">'Correction of hypercortisolism'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/1\" class=\"nounderline abstract_t\">Bourdeau I, Bard C, Forget H, et al. Cognitive function and cerebral assessment in patients who have Cushing's syndrome. Endocrinol Metab Clin North Am 2005; 34:357.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/2\" class=\"nounderline abstract_t\">Andela CD, van Haalen FM, Ragnarsson O, et al. MECHANISMS IN ENDOCRINOLOGY: Cushing's syndrome causes irreversible effects on the human brain: a systematic review of structural and functional magnetic resonance imaging studies. Eur J Endocrinol 2015; 173:R1.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/3\" class=\"nounderline abstract_t\">Pivonello R, Simeoli C, De Martino MC, et al. Neuropsychiatric disorders in Cushing's syndrome. Front Neurosci 2015; 9:129.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/4\" class=\"nounderline abstract_t\">de Kloet ER, Otte C, Kumsta R, et al. Stress and Depression: a Crucial Role of the Mineralocorticoid Receptor. J Neuroendocrinol 2016; 28.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/5\" class=\"nounderline abstract_t\">Wolf OT, Atsak P, de Quervain DJ, et al. Stress and Memory: A Selective Review on Recent Developments in the Understanding of Stress Hormone Effects on Memory and Their Clinical Relevance. J Neuroendocrinol 2016; 28.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/6\" class=\"nounderline abstract_t\">De Kloet ER, Vreugdenhil E, Oitzl MS, Jo&euml;ls M. Brain corticosteroid receptor balance in health and disease. Endocr Rev 1998; 19:269.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/7\" class=\"nounderline abstract_t\">Berardelli R, Karamouzis I, D'Angelo V, et al. Role of mineralocorticoid receptors on the hypothalamus-pituitary-adrenal axis in humans. Endocrine 2013; 43:51.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/8\" class=\"nounderline abstract_t\">Gomez-Sanchez EP. Brain mineralocorticoid receptors in cognition and cardiovascular homeostasis. Steroids 2014; 91:20.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/9\" class=\"nounderline abstract_t\">Holmes MC, Yau JL, Kotelevtsev Y, et al. 11 Beta-hydroxysteroid dehydrogenases in the brain: two enzymes two roles. Ann N Y Acad Sci 2003; 1007:357.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/10\" class=\"nounderline abstract_t\">Rajan V, Edwards CR, Seckl JR. 11 beta-Hydroxysteroid dehydrogenase in cultured hippocampal cells reactivates inert 11-dehydrocorticosterone, potentiating neurotoxicity. J Neurosci 1996; 16:65.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/11\" class=\"nounderline abstract_t\">Jo&euml;ls M, Pasricha N, Karst H. The interplay between rapid and slow corticosteroid actions in brain. Eur J Pharmacol 2013; 719:44.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/12\" class=\"nounderline abstract_t\">Hua SY, Chen YZ. Membrane receptor-mediated electrophysiological effects of glucocorticoid on mammalian neurons. Endocrinology 1989; 124:687.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/13\" class=\"nounderline abstract_t\">Ruf K, Steiner FA. Steroid-sensitive single neurons in rat hypothalamus and midbrain: identification by microelectrophoresis. Science 1967; 156:667.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/14\" class=\"nounderline abstract_t\">Mandelbrod I, Feldman S, Werman R. Inhibition of firing is the primary effect of microelectrophoresis of cortisol to units in the rat tuberal hypothalamus. Brain Res 1974; 80:303.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/15\" class=\"nounderline abstract_t\">Scheff SW, Benardo LS, Cotman CW. Hydrocortison administration retards axon sprouting in the rat dentate gyrus. Exp Neurol 1980; 68:195.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/16\" class=\"nounderline abstract_t\">Scheff SW, Cotman CW. Chronic glucocorticoid therapy alters axon sprouting in the hippocampal dentate gyrus. Exp Neurol 1982; 76:644.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/17\" class=\"nounderline abstract_t\">Sapolsky RM, Krey LC, McEwen BS. Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging. J Neurosci 1985; 5:1222.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/18\" class=\"nounderline abstract_t\">Hunter RG, Seligsohn M, Rubin TG, et al. Stress and corticosteroids regulate rat hippocampal mitochondrial DNA gene expression via the glucocorticoid receptor. Proc Natl Acad Sci U S A 2016; 113:9099.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/19\" class=\"nounderline abstract_t\">Chen H, Lomb&egrave;s M, Le Menuet D. Glucocorticoid receptor represses brain-derived neurotrophic factor expression in neuron-like cells. Mol Brain 2017; 10:12.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/20\" class=\"nounderline abstract_t\">Juurlink BH, Schousboe A, J&oslash;rgensen OS, Hertz L. Induction by hydrocortisone of glutamine synthetase in mouse primary astrocyte cultures. J Neurochem 1981; 36:136.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/21\" class=\"nounderline abstract_t\">Hallermayer K, Harmening C, Hamprecht B. Cellular localization and regulation of glutamine synthetase in primary cultures of brain cells from newborn mice. J Neurochem 1981; 37:43.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/22\" class=\"nounderline abstract_t\">Patel AJ, Hunt A. Observations on cell growth and regulation of glutamine synthetase by dexamethasone in primary cultures of forebrain and cerebellar astrocytes. Brain Res 1985; 350:175.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/23\" class=\"nounderline abstract_t\">McCarthy KD, de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 1980; 85:890.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/24\" class=\"nounderline abstract_t\">Cammer W, Snyder DS, Zimmerman TR Jr, et al. Glycerol phosphate dehydrogenase, glucose-6-phosphate dehydrogenase, and lactate dehydrogenase: activities in oligodendrocytes, neurons, astrocytes, and myelin isolated from developing rat brains. J Neurochem 1982; 38:360.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/25\" class=\"nounderline abstract_t\">Kumar S, Holmes E, Scully S, et al. The hormonal regulation of gene expression of glial markers: glutamine synthetase and glycerol phosphate dehydrogenase in primary cultures of rat brain and in C6 cell line. J Neurosci Res 1986; 16:251.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/26\" class=\"nounderline abstract_t\">Sapolsky RM. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 2000; 57:925.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/27\" class=\"nounderline abstract_t\">Mirescu C, Peters JD, Noiman L, Gould E. Sleep deprivation inhibits adult neurogenesis in the hippocampus by elevating glucocorticoids. Proc Natl Acad Sci U S A 2006; 103:19170.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/28\" class=\"nounderline abstract_t\">Webster JC, Huber RM, Hanson RL, et al. Dexamethasone and tumor necrosis factor-alpha act together to induce the cellular inhibitor of apoptosis-2 gene and prevent apoptosis in a variety of cell types. Endocrinology 2002; 143:3866.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/29\" class=\"nounderline abstract_t\">Merke DP, Chrousos GP, Eisenhofer G, et al. Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency. N Engl J Med 2000; 343:1362.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/30\" class=\"nounderline abstract_t\">Zuckerman-Levin N, Tiosano D, Eisenhofer G, et al. The importance of adrenocortical glucocorticoids for adrenomedullary and physiological response to stress: a study in isolated glucocorticoid deficiency. J Clin Endocrinol Metab 2001; 86:5920.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/31\" class=\"nounderline abstract_t\">Le Douarin NM. Cell line segregation during peripheral nervous system ontogeny. Science 1986; 231:1515.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/32\" class=\"nounderline abstract_t\">Thoenen H, Barde YA. Physiology of nerve growth factor. Physiol Rev 1980; 60:1284.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/33\" class=\"nounderline abstract_t\">Anderson DJ, Axel R. Molecular probes for the development and plasticity of neural crest derivatives. Cell 1985; 42:649.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/34\" class=\"nounderline abstract_t\">Anderson DJ, Axel R. A bipotential neuroendocrine precursor whose choice of cell fate is determined by NGF and glucocorticoids. Cell 1986; 47:1079.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/35\" class=\"nounderline abstract_t\">Federoff HJ, Grabczyk E, Fishman MC. Dual regulation of GAP-43 gene expression by nerve growth factor and glucocorticoids. J Biol Chem 1988; 263:19290.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/36\" class=\"nounderline abstract_t\">Chen YF, Li YF, Chen X, Sun QF. Neuropsychiatric disorders and cognitive dysfunction in patients with Cushing's disease. Chin Med J (Engl) 2013; 126:3156.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/37\" class=\"nounderline abstract_t\">Le&oacute;n-Carri&oacute;n J, Atutxa AM, Mangas MA, et al. A clinical profile of memory impairment in humans due to endogenous glucocorticoid excess. Clin Endocrinol (Oxf) 2009; 70:192.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/38\" class=\"nounderline abstract_t\">Starkman MN, Giordani B, Berent S, et al. Elevated cortisol levels in Cushing's disease are associated with cognitive decrements. Psychosom Med 2001; 63:985.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/39\" class=\"nounderline abstract_t\">Forget H, Lacroix A, Cohen H. Persistent cognitive impairment following surgical treatment of Cushing's syndrome. Psychoneuroendocrinology 2002; 27:367.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/40\" class=\"nounderline abstract_t\">Grillon C, Smith K, Haynos A, Nieman LK. Deficits in hippocampus-mediated Pavlovian conditioning in endogenous hypercortisolism. Biol Psychiatry 2004; 56:837.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/41\" class=\"nounderline abstract_t\">Jameison K, Dinan TG. Glucocorticoids and cognitive function: from physiology to pathophysiology. Hum Psychopharmacol 2001; 16:293.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/42\" class=\"nounderline abstract_t\">Hinkelmann K, Wingenfeld K, Kuehl LK, et al. Stimulation of the mineralocorticoid receptor improves memory in young and elderly healthy individuals. Neurobiol Aging 2015; 36:919.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/43\" class=\"nounderline abstract_t\">Brunner R, Schaefer D, Hess K, et al. Effect of corticosteroids on short-term and long-term memory. Neurology 2005; 64:335.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/44\" class=\"nounderline abstract_t\">Radecki DT, Brown LM, Martinez J, Teyler TJ. BDNF protects against stress-induced impairments in spatial learning and memory and LTP. Hippocampus 2005; 15:246.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/45\" class=\"nounderline abstract_t\">Lupien SJ, Maheu F, Tu M, et al. The effects of stress and stress hormones on human cognition: Implications for the field of brain and cognition. Brain Cogn 2007; 65:209.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/46\" class=\"nounderline abstract_t\">Grottoli S, Giordano R, Maccagno B, et al. The stimulatory effect of canrenoate, a mineralocorticoid antagonist, on the activity of the hypothalamus-pituitary-adrenal axis is abolished by alprazolam, a benzodiazepine, in humans. J Clin Endocrinol Metab 2002; 87:4616.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/47\" class=\"nounderline abstract_t\">Meijer OC, de Kloet ER. A Refill for the Brain Mineralocorticoid Receptor: The Benefit of Cortisol Add-On to Dexamethasone Therapy. Endocrinology 2017; 158:448.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/48\" class=\"nounderline abstract_t\">Starkman MN, Schteingart DE, Schork MA. Correlation of bedside cognitive and neuropsychological tests in patients with Cushing's syndrome. Psychosomatics 1986; 27:508.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/49\" class=\"nounderline abstract_t\">Watson S, Gallagher P, Del-Estal D, et al. Hypothalamic-pituitary-adrenal axis function in patients with chronic depression. Psychol Med 2002; 32:1021.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/50\" class=\"nounderline abstract_t\">Reus VI, Wolkowitz OM. Antiglucocorticoid drugs in the treatment of depression. Expert Opin Investig Drugs 2001; 10:1789.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/51\" class=\"nounderline abstract_t\">Young EA, Lopez JF, Murphy-Weinberg V, et al. Hormonal evidence for altered responsiveness to social stress in major depression. Neuropsychopharmacology 2000; 23:411.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/52\" class=\"nounderline abstract_t\">Merke DP, Giedd JN, Keil MF, et al. Children experience cognitive decline despite reversal of brain atrophy one year after resolution of Cushing syndrome. J Clin Endocrinol Metab 2005; 90:2531.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/53\" class=\"nounderline abstract_t\">Momose KJ, Kjellberg RN, Kliman B. High incidence of cortical atrophy of the cerebral and cerebellar hemispheres in Cushing's disease. Radiology 1971; 99:341.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/54\" class=\"nounderline abstract_t\">TRETHOWAN WH, COBB S. Neuropsychiatric aspects of Cushing's syndrome. AMA Arch Neurol Psychiatry 1952; 67:283.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/55\" class=\"nounderline abstract_t\">COPE O, RAKER JW. Cushing's disease: the surgical experience in the care of 46 cases. N Engl J Med 1955; 253:119.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/56\" class=\"nounderline abstract_t\">Bourdeau I, Bard C, No&euml;l B, et al. Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism. J Clin Endocrinol Metab 2002; 87:1949.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/57\" class=\"nounderline abstract_t\">Starkman MN, Gebarski SS, Berent S, Schteingart DE. Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biol Psychiatry 1992; 32:756.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/58\" class=\"nounderline abstract_t\">Simmons NE, Do HM, Lipper MH, Laws ER Jr. Cerebral atrophy in Cushing's disease. Surg Neurol 2000; 53:72.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/59\" class=\"nounderline abstract_t\">Santos A, Resmini E, Crespo I, et al. Small cerebellar cortex volume in patients with active Cushing's syndrome. Eur J Endocrinol 2014; 171:461.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/60\" class=\"nounderline abstract_t\">Bentson J, Reza M, Winter J, Wilson G. Steroids and apparent cerebral atrophy on computed tomography scans. J Comput Assist Tomogr 1978; 2:16.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/61\" class=\"nounderline abstract_t\">Zanardi VA, Magna LA, Costallat LT. Cerebral atrophy related to corticotherapy in systemic lupus erythematosus (SLE). Clin Rheumatol 2001; 20:245.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/62\" class=\"nounderline abstract_t\">Marchesi C, De Risio C, Campanini G, et al. Cerebral atrophy and plasma cortisol levels in alcoholics after short or a long period of abstinence. Prog Neuropsychopharmacol Biol Psychiatry 1994; 18:519.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/63\" class=\"nounderline abstract_t\">Rothschild AJ, Benes F, Hebben N, et al. Relationships between brain CT scan findings and cortisol in psychotic and nonpsychotic depressed patients. Biol Psychiatry 1989; 26:565.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/64\" class=\"nounderline abstract_t\">Sheline YI, Wang PW, Gado MH, et al. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A 1996; 93:3908.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/65\" class=\"nounderline abstract_t\">Bremner JD, Narayan M, Anderson ER, et al. Hippocampal volume reduction in major depression. Am J Psychiatry 2000; 157:115.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/66\" class=\"nounderline abstract_t\">Bremner JD, Randall P, Scott TM, et al. MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am J Psychiatry 1995; 152:973.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/67\" class=\"nounderline abstract_t\">Tijsseling D, Wijnberger LD, Derks JB, et al. Effects of antenatal glucocorticoid therapy on hippocampal histology of preterm infants. PLoS One 2012; 7:e33369.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/68\" class=\"nounderline abstract_t\">Khiat A, Bard C, Lacroix A, et al. Brain metabolic alterations in Cushing's syndrome as monitored by proton magnetic resonance spectroscopy. NMR Biomed 1999; 12:357.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/69\" class=\"nounderline abstract_t\">Liu S, Wang Y, Xu K, et al. Brain glucose metabolism is associated with hormone level in Cushing's disease: A voxel-based study using FDG-PET. Neuroimage Clin 2016; 12:415.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/70\" class=\"nounderline abstract_t\">Khiat A, Yared Z, Bard C, et al. Long-term brain metabolic alterations in exogenous Cushing's syndrome as monitored by proton magnetic resonance spectroscopy. Brain Res 2001; 911:134.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/71\" class=\"nounderline abstract_t\">Maheu FS, Mazzone L, Merke DP, et al. Altered amygdala and hippocampus function in adolescents with hypercortisolemia: a functional magnetic resonance imaging study of Cushing syndrome. Dev Psychopathol 2008; 20:1177.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/72\" class=\"nounderline abstract_t\">Starkman MN, Giordani B, Gebarski SS, et al. Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease. Biol Psychiatry 1999; 46:1595.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/73\" class=\"nounderline abstract_t\">Toffanin T, Nifos&igrave; F, Follador H, et al. Volumetric MRI analysis of hippocampal subregions in Cushing's disease: a model for glucocorticoid neural modulation. Eur Psychiatry 2011; 26:64.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/74\" class=\"nounderline abstract_t\">Keil MF, Zametkin A, Ryder C, et al. Cases of Psychiatric Morbidity in Pediatric Patients After Remission of Cushing Syndrome. Pediatrics 2016; 137.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/75\" class=\"nounderline abstract_t\">Crespo I, Esther GM, Santos A, et al. Impaired decision-making and selective cortical frontal thinning in Cushing's syndrome. Clin Endocrinol (Oxf) 2014; 81:826.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/76\" class=\"nounderline abstract_t\">Forget H, Lacroix A, Bourdeau I, Cohen H. Long-term cognitive effects of glucocorticoid excess in Cushing's syndrome. Psychoneuroendocrinology 2016; 65:26.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/77\" class=\"nounderline abstract_t\">van der Werff SJ, Andela CD, Nienke Pannekoek J, et al. Widespread reductions of white matter integrity in patients with long-term remission of Cushing's disease. Neuroimage Clin 2014; 4:659.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/78\" class=\"nounderline abstract_t\">Khiat A, Bard C, Lacroix A, Boulanger Y. Recovery of the brain choline level in treated Cushing's patients as monitored by proton magnetic resonance spectroscopy. Brain Res 2000; 862:301.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/79\" class=\"nounderline abstract_t\">Resmini E, Santos A, G&oacute;mez-Anson B, et al. Hippocampal dysfunction in cured Cushing's syndrome patients, detected by (1) H-MR-spectroscopy. Clin Endocrinol (Oxf) 2013; 79:700.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/80\" class=\"nounderline abstract_t\">Crespo I, Santos A, G&oacute;mez-Ans&oacute;n B, et al. Brain metabolite abnormalities in ventromedial prefrontal cortex are related to duration of hypercortisolism and anxiety in patients with Cushing's syndrome. Endocrine 2016; 53:848.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/81\" class=\"nounderline abstract_t\">Bas-Hoogendam JM, Andela CD, van der Werff SJ, et al. Altered neural processing of emotional faces in remitted Cushing's disease. Psychoneuroendocrinology 2015; 59:134.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/82\" class=\"nounderline abstract_t\">van der Werff SJ, Pannekoek JN, Andela CD, et al. Resting-State Functional Connectivity in Patients with Long-Term Remission of Cushing's Disease. Neuropsychopharmacology 2015; 40:1888.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/83\" class=\"nounderline abstract_t\">Pires P, Santos A, Vives-Gilabert Y, et al. White matter alterations in the brains of patients with active, remitted, and cured cushing syndrome: a DTI study. AJNR Am J Neuroradiol 2015; 36:1043.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/84\" class=\"nounderline abstract_t\">Valassi E, Crespo I, Keevil BG, et al. Affective alterations in patients with Cushing's syndrome in remission are associated with decreased BDNF and cortisone levels. Eur J Endocrinol 2017; 176:221.</a></li><li><a href=\"https://www.uptodate.com/contents/glucocorticoid-effects-on-the-nervous-system-and-behavior/abstract/85\" class=\"nounderline abstract_t\">Tiemensma J, Biermasz NR, Middelkoop HA, et al. Increased prevalence of psychopathology and maladaptive personality traits after long-term cure of Cushing's disease. J Clin Endocrinol Metab 2010; 95:E129.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 134 Version 8.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H16\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">EFFECTS ON CENTRAL NERVOUS SYSTEM</a><ul><li><a href=\"#H3\" id=\"outline-link-H3\">Intracellular receptors</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">Metabolism of glucocorticoids</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">Acute versus chronic effects</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">Apoptosis</a></li></ul></li><li><a href=\"#H7\" id=\"outline-link-H7\">AUTONOMIC NERVOUS SYSTEM AND ADRENAL MEDULLA</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">EFFECTS OF GLUCOCORTICOID EXCESS</a><ul><li><a href=\"#H9\" id=\"outline-link-H9\">Behavior</a><ul><li><a href=\"#H10\" id=\"outline-link-H10\">- Cognition and memory</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">- Mood</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">- Sleep</a></li></ul></li><li><a href=\"#H13\" id=\"outline-link-H13\">Loss of brain volume</a></li><li><a href=\"#H14\" id=\"outline-link-H14\">Brain metabolic and functional changes</a></li></ul></li><li><a href=\"#H15\" id=\"outline-link-H15\">CORRECTION OF HYPERCORTISOLISM</a></li><li><a href=\"#H16\" id=\"outline-link-H16\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-and-evaluation-of-glucocorticoid-induced-osteoporosis\" class=\"medical medical_review\">Clinical features and evaluation of glucocorticoid-induced osteoporosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-and-clinical-manifestations-of-cushings-syndrome\" class=\"medical medical_review\">Epidemiology and clinical manifestations of Cushing's syndrome</a></li></ul></div></div>","javascript":null}